We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Eggshell Layer Makes Bird Virus Highly Infectious

By LabMedica International staff writers
Posted on 29 Aug 2017
Researchers have likely solved the mystery question of why human-to-human transmission of avian influenza viruses is much lower than from birds to humans. More...
They discovered that in birds an eggshell-like mineral outer layer forms around the virus and provided an explanation of how this would increase the virus’ infectiveness.

The study, by researchers from Zhejiang University (Hangzhou, Zhejiang Province, China), also found that these mineralized viruses are more robust and heat stable than the native viruses.

Avian flu is a highly infectious disease among birds that has developed into a serious threat to human health. Close contact with diseased birds or their feces is considered to be the primary source of infections in humans. Transmission between humans is limited, however, which has indicated that these viruses cannot directly infect humans. Previously it was assumed that these viruses crossed the species barrier as a result of mutation, or recombination with DNA from another pathogen, but more recent results demonstrated that avian flu viruses isolated from infected humans have the same gene sequences as those from birds.

So how is it that humans catch the disease from birds? The researcher team, working with Dr. Ruikang Tang, professor at Zhejiang University, claims this is because the viruses acquire a mineral “shell” in the bird intestines. They discovered that viruses can become mineralized under calcium-rich conditions. Naturally, the digestive tract of birds—the primary location of avian flu viruses—provides just such a calcium-rich environment so that the birds can make eggshells. In humans, avian flu viruses infect the airways and are then found in bodily fluids, where the calcium concentration is too low for mineralization.

Experiments with a solution that imitates the bird intestine environment allowed the researchers to demonstrate that 5-6 nm thick shells of a calcium phosphate (CaP) mineral form around H9N2 and H1N1 viruses. In both cell cultures and mice, these mineralized viruses proved to be significantly more infectious and deadly than the native viruses.

The mineralized shell changes the electric surface potential of the viruses. This causes mineralized viruses to adsorb much more efficiently onto the surfaces of future host cells. The mechanism for uptake into the host is also different. Normally, the virus docks at receptors on the cell surface and is then brought into the cell. The mineral layer inhibits this—but clearly stimulates very efficient uptake on its own by mainly physical (physics-based) rather than chemical means. Furthermore: within the cell, the mineralized viruses enter into lysosomes, whose slightly acidic environment dissolves the mineral shell and releases the viruses.

This new information explains why humans are more likely to catch avian flu from birds than from their fellow humans, and may help in the development of new approaches to battling avian flu.

The study, by Zhou H et al, was published August 18, 2017, in the journal Angewandte Chemie International Edition.

Related Links:
Zhejiang University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.